ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference
Rhea-AI Summary
ANI Pharmaceuticals (ANIP) has announced its participation in the upcoming Guggenheim Biotech Conference in New York City. The company's President and CEO Nikhil Lalwani and CFO Stephen Carey will conduct a fireside chat on Wednesday, February 5, 2025, at 2:00pm EST.
The presentation will be available through a live webcast, which can be accessed through ANI Pharmaceuticals' website under the Investors section's Events and Presentations area. For those unable to attend, the webcast recording will remain accessible for 60 days following the event.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, ANIP gained 0.40%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
PRINCETON, N.J., Jan. 28, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will host a fireside chat at the Guggenheim Biotech Conference in New York City as follows:
| Date: | Wednesday, February 5, 2025 |
| Time: | 2:00pm EST |
| Webcast: | Click here |
The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 60 days.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Established Brands business. For more information, visit www.anipharmaceuticals.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
FAQ
When is ANI Pharmaceuticals (ANIP) presenting at the Guggenheim Biotech Conference 2025?
How long will the ANIP Guggenheim Conference webcast be available for replay?
Where can investors access the ANIP Guggenheim Conference presentation webcast?
Who will be representing ANIP at the Guggenheim Biotech Conference 2025?
